Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Make the most of the world of different opinions – Creating Inclusivity in Pharma R&D

Posted on September 6th, 2017 by in Pharma R&D

Opinions matter; they can drive our behaviors. Within the context of Pharma R&D, it is important to harness the benefits of different views, to think outside the box, innovate and beat the safety of group thinking.

Continue reading “Make the most of the world of different opinions – Creating Inclusivity in Pharma R&D” »

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 by in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »

The certainty of uncertainty

Posted on July 17th, 2017 by in Pharma R&D

The recent election results in France and the UK once again show that a week is a long time in politics. Who would have thought when the UK voted to Brexit that Emmanuel Macron would sweep into power following the creation of his new political party in April 2016? Continue reading “The certainty of uncertainty” »

Changing perceptions by measuring inputs and outputs?

Posted on May 12th, 2017 by in Pharma R&D

 

Perception is reality. I am sure everyone will have had an experience (or will do so shortly) where their perception of a situation is at odds with the perception of another. We all have our individual styles and preferences. Continue reading “Changing perceptions by measuring inputs and outputs?” »

  1. 1
  2. 2
  3. 3